Advertisement
Advertisement

RCEL

RCEL logo

Avita Medical, Inc. Common Stock

3.95
USD
Sponsored
+0.03
+0.77%
Jun 24, 15:59 UTC -4
Closed
exchange

Pre-Market

3.95

0.00
0.00%

RCEL Earnings Reports

Positive Surprise Ratio

RCEL beat 7 of 17 last estimates.

41%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$20.33M
/
-$0.31
Implied change from Q1 26 (Revenue/ EPS)
+5.62%
/
-11.43%
Implied change from Q2 25 (Revenue/ EPS)
+10.39%
/
-18.42%

Avita Medical, Inc. Common Stock earnings per share and revenue

On May 14, 2026, RCEL reported earnings of -0.35 USD per share (EPS) for Q1 26, missing the estimate of -0.28 USD, resulting in a -22.55% surprise. Revenue reached 19.25 million, compared to an expected 18.54 million, with a 3.84% difference. The market reacted with a +4.59% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 20.33 million USD, implying an decrease of -11.43% EPS, and increase of 5.62% in Revenue from the last quarter.
FAQ
For Q1 2026, Avita Medical, Inc. Common Stock reported EPS of -$0.35, missing estimates by -22.55%, and revenue of $19.25M, 3.84% above expectations.
The stock price moved up 4.59%, changed from $4.36 before the earnings release to $4.56 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 5 analysts, Avita Medical, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of $20.33M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement